Search

Author/Creator Ansell, Peter

1. ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM). (11th November 2019)

Authors:
Lassman, Andrew; Pugh, Stephanie; Wang, Tony; Aldape, Kenneth; Gan, Hui; Preusser, Matthias; Vogelbaum, Michael; Sulman, Erik; Won, Minhee; Zhang, Peixin; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; Seidel, Clemens; De...
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 6
Page Start:
vi17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. ACTR-39. TWO-YEAR RESULTS OF THE INTELLANCE 2/EORTC TRIAL 1410 RANDOMIZED PHASE II STUDY ON DEPATUX–M ALONE, DEPATUX-M COMBINED WITH TEMOZOLOMIDE (TMZ) AND EITHER TMZ OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA (NCT02343406. (5th November 2018)

Authors:
van den Bent, Martin; French, Pim; Eoli, Marica; Sepulveda, Juan; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul; Weller, Michael; de Heer, Iris; Looman, Jim; Dey, Jyotirmoy; Krause, Scott; Xiong, Hao; Ansell, Peter; Nuyens, Sarah; Brilhante, Joana; Spruyt, Maarten...
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. Issue 1 (December 2016)

Authors:
Wang, Jieyi; Goetsch, Liliane; Tucker, Lora; Zhang, Qian; Gonzalez, Alexandra; Vaidya, Kedar; Oleksijew, Anatol; Boghaert, Erwin; Song, Minghao; Sokolova, Irina; Pestova, Ekaterina; Anderson, Mark; Pappano, William; Ansell, Peter; Bhathena, Anahita; Naumovski, Louie; Corvaia, Nathalie; Reilly, Ed...
Journal:
BMC cancer
Issue:
Volume 16:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. CTNI-51. NEUROCOGNITIVE FUNCTION (NCF) OUTCOMES OF RTOG FOUNDATION 3508: A PHASE 3 TRIAL OF ABT-414 WITH CONCURRENT CHEMORADIATION AND ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH EGFR-AMPLIFIED NEWLY DIAGNOSED GBM. (9th November 2020)

Authors:
Wefel, Jeffrey S; Won, Minhee; Lassman, Andrew; Stern, Yaakov; Wang, Tony; Aldape, Kenneth; Armstrong, Terri; Vogelbaum, Michael; Sulman, Erik; Moazami, Golnaz; Macsai, Marian; Gilbert, Mark; Bain, Earle; Blot, Vincent; Gan, Hui; Preusser, Matthias; Ansell, Peter; Samanta, Suvajit; Kundu, Madan; ...
Journal:
Neuro-oncology
Issue:
Volume 22(2020)Supplement 2
Page Start:
ii54
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial. Issue 2 (February 2020)

Authors:
Golshan, Mehra; Wong, Stephanie M.; Loibl, Sibylle; Huober, Jens Bodo; O'Shaughnessy, Joyce; Rugo, Hope S.; Wolmark, Norman; Ansell, Peter; Maag, David; Sullivan, Danielle M.; Metzger-Filho, Otto; Von Minckwitz, Gunter; Geyer, Charles E.; Sikov, William M.; Untch, Michael
Journal:
European journal of surgical oncology
Issue:
Volume 46:Issue 2(2020)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. EGFR mutations are associated with response to depatux-m in combination with temozolomide and result in a receptor that is hypersensitive to ligand. Issue 1 (9th December 2019)

Authors:
Hoogstrate, Youri; Vallentgoed, Wies; Kros, Johan M; de Heer, Iris; de Wit, Maurice; Eoli, Marica; Sepulveda, Juan Manuel; Walenkamp, Annemiek M E; Frenel, Jean-Sebastien; Franceschi, Enrico; Clement, Paul M; Weller, Micheal; van Royen, Martin E; Ansell, Peter; Looman, Jim; Bain, Earle; Morfouace...
Journal:
Neuro-oncology advances
Issue:
Volume 2:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. HGG-15. PHASE 2 NESTED COHORT STUDY OF DEPATUXIZUMAB MAFODOTIN IN CHILDREN WITH HIGH GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA WITH EGFR AMPLIFICATION. Issue 2 (22nd June 2018)

Authors:
van den Bent, Martin; Dinjens, Winand; Golfinopoulos, Vassilis; Ansell, Peter; Dungey, Fiona; de Geus, Jan Peter; Bain, Earle; Looman, Jim; Xiong, Hao; Hargrave, Darren
Journal:
Neuro-oncology
Issue:
Volume 20:Issue 2(2018)supplement 2
Page Start:
i91
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma. Issue 2 (25th July 2012)

Authors:
Toh, Han Chong; Chen, Pei‐Jer; Carr, Brian I.; Knox, Jennifer J.; Gill, Sharlene; Ansell, Peter; McKeegan, Evelyn M.; Dowell, Barry; Pedersen, Michelle; Qin, Qin; Qian, Jiang; Scappaticci, Frank A.; Ricker, Justin L.; Carlson, Dawn M.; Yong, Wei Peng
Journal:
Cancer
Issue:
Volume 119:Issue 2(2013)
Page Start:
380
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Issue 1 (21st December 2022)

Authors:
Carneiro, Benedito A; Papadopoulos, Kyriakos P; Strickler, John H; Lassman, Andrew B; Waqar, Saiama N; Chae, Young Kwang; Patel, Jyoti D; Shacham-Shmueli, Einat; Kelly, Karen; Khasraw, Mustafa; Bestvina, Christine M; Merrell, Ryan; Huang, Kevin; Atluri, Harisha; Ansell, Peter; Li, Rachel; Jin, Ja...
Journal:
Neuro-oncology advances
Issue:
Volume 5:Issue 1(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study. Issue 32 (10th November 2021)

Authors:
Ramalingam, Suresh S.; Novello, Silvia; Guclu, Salih Zeki; Bentsion, Dmitry; Zvirbule, Zanete; Szilasi, Maria; Bernabe, Reyes; Syrigos, Konstantinos; Byers, Lauren Averett; Clingan, Philip; Bar, Jair; Vokes, Everett E.; Govindan, Ramaswamy; Dunbar, Martin; Ansell, Peter; He, Lei; Huang, Xin; Sehg...
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 32(2021)
Page Start:
3633
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗